US
New NAFTA terms put hold on Canadian drug prices
December 11, 2019Research and Development, Sales and Marketing Canada, NAFTA, US, pharma
NAFTA members have agreed to remove a provision that would have increased protections on biologics drugs. This means Canada, despite …
Top Ten most popular articles on Pharmafile.com this week
November 29, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boris Johnson, Jeremy Corbyn, NHS, Opiod, US, opiod crisis
The NHS was featured heavily in the news this week. Jeremy Corbyn revealed documents detailing previous UK-US discussions in which …
Corbyn reveals documents showing US-UK meetings on deregulating NHS drug pricing
November 27, 2019Research and Development, Sales and Marketing Jeremy Corbyn, Labour Party, NHS, US, pharma
Labour Leader Jeremy Corbyn has showed off documents that detail secret trade meetings between the US and UK Governments, where …
Lilly to boost Indianapolis manufacturing site with $400m injection, 100 jobs to be created
November 20, 2019Manufacturing and Production, Research and Development Eli Lilly, US, pharma
Eli Lilly is poised to boost its manufacturing capacity with the investment of $400 million at its Lilly Technology Center …
Amgen poised to cut 172 positions across US, including California HQ
November 19, 2019Manufacturing and Production Amgen, US, pharma
As revealed in correspondence with the California Employment Development Department, Amgen plans to axe 172 staff positions across the US, …
Donald Trump nominates Dr Stephen Hahn as next FDA Commissioner
November 4, 2019Medical Communications, Sales and Marketing Donald Trump, FDA, Ned Sharpless, President trump, Scott Gottlieb, Trump, US
The US FDA could be set to receive its next long-term Commissioner after the White House revealed President Donald Trump’s …
2019 saw the FDA approve more generic drugs than ever before
October 18, 2019Medical Communications, Sales and Marketing FDA, US, generic drugs, pharma
Fiscal year 2019 was a record-breaking one, according to the FDA. The US regulator smashed its previous total for annual …
FDA greenlights Genentech’s Xofluza for acute, uncomplicated influenza
October 18, 2019Medical Communications FDA, Genetech, Roche, US, Xofluza, flu, pharma
Roche subsidiary Genentech has announced that its polymerase acidic endonuclease inhibitor Xofluza (baloxavir marboxil) has been awarded FDA approval in …
FDA approves first and only transdermal patch for schizophrenia
October 16, 2019Research and Development, Sales and Marketing FDA, Noven Pharma, Secuado, US, pharma, schizophrenia
Hisamitsu Pharmaceutical subsidiary Noven Pharmaceuticals has revealed the FDA approval of Secuado (asenapine) in adult schizophrenia patients, making it the …
Lilly’s Reyvow becomes first FDA-approved 5-HT1F receptor agonist for acute migraine
October 15, 2019Manufacturing and Production, Sales and Marketing Eli Lilly, FDA, Reyvow, US, migraine, pharma
Eli Lilly has announced that the FDA has given the green light to Reyvow (lasmiditan) in the acute treatment of …
FDA approves Janssen’s Xarelto for blood clot prevention
October 15, 2019Manufacturing and Production, Sales and Marketing FDA, Janssen, US, Xarelto, pharma, thromboembolism
Janssen’s Xarelto (rivaroxaban) has secured FDA approval for the prevention of venous thromboembolism (VTE), or blood clots, in hospitalised acutely …
Biotechnology Innovation Organization Chief to step down after US 2020 elections
October 11, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biotechnology Innovation Organization, US, biotech, pharma
The Biotechnology Innovation Organization (BIO), the largest trade body representing the world’s biotechnology industry, has revealed that its President and …
Boehringer’s Ofev scores first-of-its-kind FDA approval in rare lung disease
September 10, 2019Manufacturing and Production, Sales and Marketing Boehringer Ingelheim, FDA, US, lungs, ofev, pharma, rare disease
Boehringer Ingelheim’s Ofev (nintedanib) capsules have now secured marketing authorisation in the US, it has emerged, for the treatment of …
Trump’s FDA: Is the US regulator being steered by the President?
September 9, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Trump, US, drug safety, pharma
FDA activity has fallen under Donald Trump, with the number of warning letters issued by the regulator dropping by a …
View of pharma industry sinks to new low in US, poll reveals
September 6, 2019Medical Communications US, pharma
The public have always been reticent with their trust in the pharmaceutical industry, but that trust has hit an all-time …
Latest content
FibroFind appoints Lee Borthwick as CEO
